Daxor Corporation  

(Public, NYSEMKT:DXR)   Watch this stock  
Find more results for Martin Mombard´┐Ż
0.00 (0.00%)
Nov 27 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range     -
52 week 5.40 - 9.18
Open     -
Vol / Avg. 167.00/579.00
Mkt cap 33.72M
P/E     -
Div/yield 0.03/0.93
EPS -1.34
Shares 3.90M
Beta 0.05
Inst. own 4%

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin -685.94% -60.57%
Operating margin 45.04% 57.31%
EBITD margin - 57.31%
Return on average assets -23.16% -2.09%
Return on average equity -40.52% -3.83%
Employees 37 -
CDP Score - -


Suite 7120, 350 Fifth Ave.
NEW YORK, NY 10118
United States - Map
+1-212-2440555 (Phone)
+1-212-2440806 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Daxor Corporation is a medical instrumentation and biotechnology company. The Company designed and developed the BVA-100 Blood Volume Analyzer. BVA-100 Blood Volume Analyzer provides direct measurement of a patient's blood volume. The BVA-100 is a semi-automated Blood Volume Analyzer. It is used in conjunction with a single use diagnostic kit. The BVA-100 is used to diagnose and treat patients with heart failure, kidney failure, hypertension and syncope, and to aid in fluid and blood transfusion management. The BVA-100 has also been used to aid in the diagnosis and treatment of disorders of red blood cell volume including polycythemia and anemia, and to aid in pre-surgical evaluation of red blood cell volume. The Company’s IDANT division (IDANT Laboratories subsidiary) provides semen banking services, which include anonymous donor semen and semen storage, autologous blood storage, andrology services, which include semen analysis and sperm washing, and general lab testing.

Officers and directors

Joseph Feldschuh M.D. Chairman of the Board, President
Age: 80
Bio & Compensation  - Reuters
Michael Feldschuh Director
Age: 45
Bio & Compensation  - Reuters
James A. Lombard Independent Director
Age: 80
Bio & Compensation  - Reuters
Bernhard Saxe Esq. Independent Director
Age: 76
Bio & Compensation  - Reuters
Robert Willens Independent Director
Age: 68
Bio & Compensation  - Reuters
Martin S. Wolpoff Independent Director
Age: 72
Bio & Compensation  - Reuters